Ultomiris 300 mg/30 ml

Ultomiris 300 mg/30 ml is a medicine authorised by Swissmedic under authorisation number 67278. The authorisation holder is Alexion Pharma GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 January 2020 and the authorisation is valid without a time limit. ATC code L04AJ02 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 67278
  • ATC L04AJ02
  • Biotechnological medicines
Authorisation data
Authorisation number67278
NameUltomiris 300 mg/30 ml
Full nameUltomiris 300 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAlexion Pharma GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AJ02
First authorisation20 January 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ultomiris 300 mg/30 ml, Konzentrat zur Herstellung einer InfusionslösungA20 January 2020
2Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer InfusionslösungA16 September 2021
3Ultomiris 1100 mg/11 ml, Konzentrat zur Herstellung einer InfusionslösungA16 September 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AJ0207.15.0.A
21Durchstechflasche(n)L04AJ0207.15.0.A
31Durchstechflasche(n)L04AJ0207.15.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Ultomiris 300 mg/30 ml authorised in Switzerland?

Yes. Ultomiris 300 mg/30 ml is authorised by Swissmedic under authorisation number 67278, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ultomiris 300 mg/30 ml have?

Ultomiris 300 mg/30 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ultomiris 300 mg/30 ml?

The authorisation holder is Alexion Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com